leisure time -WSS

leisure time

author：explore 2025-09-28 19:24:55 - browse：37

Susan Galbraith of AstraZeneca gestures while speaking – pharma coverage from STAT — Susan Galbraith, AstraZeneca’s head of cancer research and development, speaks at a STAT event in 2023. Marie Miller for STAT

CHICAGO — AstraZeneca’s head of cancer research and development, Susan Galbraith, is British, and prone to a particularly British style of understatement. She doesn’t boast loudly. But she did come to this year’s annual meeting of the American Society of Clinical Oncology wearing a small lapel pin with the numeral 6 and the “AZ” corporate logo.

That pin represents the number of years in a row that the London-based drug giant has had a presentation in the ASCO plenary, the conference’s biggest showcase for new data. This year, the company has two.

Scientific credibility is great, of course. But AstraZeneca’s shareholders want something else: return on investment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： 'Screen and refer' systems are hurting patients

WSS

ADA: All diabetes patients should be screened for liver condition

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Medical experts exlpore how to eliminate bias in clinical algorithms

Skip the lead apron during X

'Screen and refer' systems are hurting patients

Eating disorder hotline's move to chatbot carried cost for volunteers

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Vertex cell therapy lets patients with type 1 diabetes stop insulin

United colonoscopy coverage change 'may cost lives,' doctors say

Lupron, used to halt puberty in children, may cause lasting health problems

In age of alternative facts, a scholarly course on calling out crap

'Screen and refer' systems are hurting patients

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Eating disorder hotline's move to chatbot carried cost for volunteers

New air purifier tech could be key to improving indoor air quality

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

hotspot

Supreme Court rules employers must be more accommodating of religious observance

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Security flaws in third

How Robert F. Kennedy Jr. distorted vaccine science

Supreme Court strikes down Biden student loan forgiveness program

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

focus

explore

hotspot

Wikipedia